199 related articles for article (PubMed ID: 34987617)
21. Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma.
Kang M; Wang Y; Yang M; Wang X; Zhu L; Zhang M
Sci Rep; 2023 Mar; 13(1):4931. PubMed ID: 36967413
[TBL] [Abstract][Full Text] [Related]
22. Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study.
Zhang CC; Hou RP; Xia WY; Zeng WQ; Liu J; Wang JM; Lv CX; Luo QQ; Zhao H; Yu W; Zhang Q; Zhu ZF; Cai XW; Feng W; Fu XL
Lung Cancer; 2021 Jun; 156():100-108. PubMed ID: 33940542
[TBL] [Abstract][Full Text] [Related]
23. A novel nomogram predicting the risk of postoperative pneumonia for esophageal cancer patients after minimally invasive esophagectomy.
Jin D; Yuan L; Li F; Wang S; Mao Y
Surg Endosc; 2022 Nov; 36(11):8144-8153. PubMed ID: 35441868
[TBL] [Abstract][Full Text] [Related]
24. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
25. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures.
Li Q; Long X; Wang Y; Fang X; Guo D; Lv J; Hu X; Cai L
BMC Musculoskelet Disord; 2021 Nov; 22(1):957. PubMed ID: 34784910
[TBL] [Abstract][Full Text] [Related]
27. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
28. Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.
Zhang XZ; Tao SP; Liang SX; Chen SB; Liu FS; Jiang W; Chen MJ
Front Immunol; 2022; 13():938795. PubMed ID: 36105795
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
Front Oncol; 2021; 11():784156. PubMed ID: 34869040
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Nomogram for Predicting Long-Term Overall Survival of Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Plus Surgery: A Population-Based Study.
Chen M; Hong Z; Shen Z; Gao L; Kang M
Front Surg; 2022; 9():927457. PubMed ID: 35693314
[TBL] [Abstract][Full Text] [Related]
31. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
32. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X
BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594
[TBL] [Abstract][Full Text] [Related]
33. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
34. Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.
Lin Y; Zheng B; Chen J; Huang Q; Ye Y; Yang Y; Chen Y; Chen B; You M; Wang Q; Xu Y
Front Oncol; 2023; 13():1059539. PubMed ID: 37124485
[TBL] [Abstract][Full Text] [Related]
35. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.
Levy DA; Li H; Sterba KR; Hughes-Halbert C; Warren GW; Nussenbaum B; Alberg AJ; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):455-464. PubMed ID: 32239201
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and novel predictive model for metastatic cutaneous squamous cell carcinoma: a population-based analysis.
Zhang H; Zhang L; Liu Y; Chen J
Arch Dermatol Res; 2023 Oct; 315(8):2339-2346. PubMed ID: 37039868
[TBL] [Abstract][Full Text] [Related]
39. Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study.
Li QW; Qiu B; Liang WH; Wang JY; Hu WM; Zhang T; Xu SB; López J; Chen NB; Guo MZ; Zhao Y; Chen LJ; Liu SR; Yun JP; Guo JY; Wang SY; Wang X; Zhang L; Yue DS; Liao ZX; Lin SH; Long H; Pang QS; Liu H
J Cancer; 2020; 11(20):6114-6121. PubMed ID: 32922551
[No Abstract] [Full Text] [Related]
40. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
